TKTL1 and neoplasm: Combining the natural immune response to cancer with the fact that tumor cells have an altered metabolism, in 2012, Feyen et al. first reported the EDIM-TKTL1 blood test to evaluate if the transketolase-like-1 (TKTL1) protein could be detected in monocytes and allow for cancer detection.